8 reports

BGI Health has years of experience applying genomic technologies in hospitals and clinics throughout China.

  • Cancer
  • Genomics
  • In Vitro Diagnostic Reagent
  • East Asia
  • OriGene Technologies, Inc.
  • BGI GENOMICS RAISES USD80 MILLION IN IPO
  • GENOMIC HEALTH ENTERS INTO LICENSING AGREEMENT WITH BIOCARTIS

China In Vitro Diagnostics (IVD) Market Outlook to 2024 - Clinical Chemistry, Genetic Testing, Hematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture Summary GlobalData’s new report, China In Vitro Diagnostics (IVD) Market Outlook to 2024, provides key...

  • Genomics
  • In Vitro Diagnostic Reagent
  • East Asia
  • Forecast
  • QIAGEN N.V.
  • SOPHIA GENETICS ENTERS INTO AGREEMENT WITH QIAGEN

(Illumina) provides genomic sequencing and array-based solutions for genetic analysis in the areas of molecular diagnostics, translational and consumer genomics, and oncology.

  • Genomics
  • In Vitro Diagnostic Reagent
  • East Asia
  • Forecast
  • QIAGEN N.V.

BERLIN, PRESIDENT AND CHIEF EXECUTIVE OFFICER OF ROSETTA GENOMICS.

  • Genomics
  • In Vitro Diagnostic Reagent
  • East Asia
  • Forecast
  • QIAGEN N.V.

" This study is a historic one for Japan.

  • Genetic
  • Genomics
  • China
  • East Asia
  • PerkinElmer, Inc.

Each ADS represents one ordinary share.

  • Genomics
  • In Vitro Diagnostic Reagent
  • In Vitro Diagnostics
  • East Asia
  • bioMerieux S.A.

Other genetic tests include pharmaco-genomics which include test related to cytochrome P## (CYP ##).

  • Genomics
  • In Vitro Diagnostic Reagent
  • East Asia
  • Market Size
  • bioMerieux S.A.

Other genetic tests include pharmaco-genomics which include test related to cytochrome P## (CYP ##).

  • Genomics
  • In Vitro Diagnostics
  • East Asia
  • Japan
  • Sosei Group Corporation